Skip to main content
logo
Neovacs S.A. (EPA:ALNEV)
France flag France · Delayed Price · Currency is EUR
0.6120
-0.0680 (-10.00%)
Aug 21, 2026, 5:35 PM CET

Neovacs Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.20.430.5300.020.03
Revenue Growth
-54.08%-18.65%47868.71%-95.07%-24.32%-68.70%
Gross Profit
-2.91-2.77-3.47-3.4-4.54-1.69
Operating Income
-5.71-6.62-6.91-6.44-7.83-3.49
Net Income
-4.36-32.91-8.74-3.55-11.84-6.14
Earnings Per Share
----0.01-5.95-0.01
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
0.040.440.896.7633.0910.07
Total Debt
0.170.230.651.21.030.39
Net Cash (Debt)
-0.130.210.245.5532.069.68
Net Cash Growth
--13.29%-95.74%-82.67%231.12%684.25%
Net Cash Per Share
---0.0216.100.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-3.09-3.6-1.91-4.45-9.91-5.65
Capital Expenditures
-0.02-0.08-0.2-0.15-0.35-0.21
Free Cash Flow
-3.11-3.68-2.12-4.6-10.26-5.86
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Margin
-2866.37%-1525.96%-1294.97%-579583.27%-34725.65%-11723.46%
Pretax Margin
-2738.87%-7823.36%-1803.52%-390822.21%-55356.01%-22442.12%
Profit Margin
-2186.98%-7585.07%-1639.15%-319109.98%-52512.21%-20624.03%
FCF Margin
-1561.34%-848.26%-396.80%-413782.37%-45498.69%-19665.26%

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Forward PE
-00000